Ciprofloxacin
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-04539 |
| CAS | 85721-33-1 |
| Molecular Weight | 331.34 |
| Molecular Formula | C17H18FN3O3 |
| Purity | >98% |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Ciprofloxacin is a fluoroquinolone antibiotic, shows broad and potent antibacterial activity, with MIC90 of 0.024-6 μM. It is active against a variety of Gram-positive and Gram-negative bacteria in vitro, including S. aureus, L. monocytogenes, P. aeruginosa, Legionella, N. gonorrhoeae and H. pylori.
- Specification
- Properties
- Toxicity
- Reference Reading
- Spectrum
- Price Product List
| Related CAS | 93107-08-5 (hydrochloride) |
| Synonyms | 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid; Bay q 3939; Ciflafin; Ciprine; Cipro IV; Ciprofloxacillin; Ciprobay; Fimoflox; Ipiflox; Probiox |
| Storage | Store at -20°C |
| IUPAC Name | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
| Canonical SMILES | C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O |
| InChI | InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24) |
| InChI Key | MYSWGUAQZAJSOK-UHFFFAOYSA-N |
| Source | Synthetic |
| Appearance | White Solid |
| Antibiotic Activity Spectrum | Gram-positive bacteria; Gram-negative bacteria |
| Boiling Point | 581.8±50.0°C (Predicted) |
| Melting Point | 253-255°C (dec.) |
| Density | 1.461±0.06 g/cm3 (Predicted) |
| Solubility | Slightly soluble in DMSO (Heated), Methanol (Heated) |
| LogP | 0.28 |
| Carcinogenicity | No indication of carcinogenicity to humans (not listed by IARC). |
| Mechanism Of Toxicity | The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, strand supercoiling repair, and recombination. |
Spectrum
Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive
Experimental Conditions
Ionization Energy: 70 eV
Chromatography Type: Gas Chromatography Column (GC)
Instrument Type: Single quadrupole, spectrum predicted by CFM-ID(EI)
Mass Resolution: 0.0001 Da
Molecular Formula: C17H18FN3O3
Molecular Weight (Monoisotopic Mass): 331.1332 Da
Molecular Weight (Avergae Mass): 331.3415 Da
LC-MS/MS Spectrum - LC-ESI-qTof , Positive
Experimental Conditions
Ionization Mode: Positive
Predicted LC-MS/MS Spectrum - 10V, Positive
Experimental Conditions
Collision Energy: 10 eV
Instrument Type: QTOF (generic), spectrum predicted by CFM-ID
Mass Resolution: 0.0001 Da
Molecular Formula: C17H18FN3O3
Molecular Weight (Monoisotopic Mass): 331.1332 Da
Molecular Weight (Avergae Mass): 331.3415 Da
13C NMR Spectrum
Experimental Conditions
Nucleus: 13C
Frequency: 100
| BBF-02575 | Pneumocandin A0 | Inquiry |
| BBF-05886 | Notoginsenoside R1 | Inquiry |
| BBF-04624 | Sulbactam Sodium | Inquiry |
| BBF-05781 | Emodepside | Inquiry |
| BBF-05827 | Spliceostatin A | Inquiry |
| BBF-00664 | Alternariol | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
